Skip to main content

Advertisement

Springer Nature Link
Log in

Commitment of measles elimination by 2020: Challenges in India

  • Perspective
  • Published:
Indian Pediatrics Aims and scope Submit manuscript

Abstract

The eleven member states of World Health Organization South-East Asia Region committed to eliminate measles by 2020. In phased manner, Government of India is working on this goal, and has introduced two-dose strategy for measles vaccine in the routine immunization. Molecular epidemiology of measles in India has been considerably growing that would be useful for understanding the circulation of wild type measles in pre- and post-elimination period. However, importations of cases from other countries may be likely. This article describes major challenges to achieve the measles elimination goal in India.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Subscribe and save

Springer+ Basic
€32.70 /Month
  • Get 10 units per month
  • Download Article/Chapter or eBook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price includes VAT (Finland)

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. World Health Organization SEARO. Measles Elimination by 2020. Available from: http://www.searo.who.int/mediacentre/releases/2013/pr1565. Accessed July 18, 2014.

  2. World Health Organization. Measles vaccines: WHO position paper. Wkly Epidemiol Rec. 2009;84:349–60.

    Google Scholar 

  3. Press Information Bureau, Government of India. Prime Minister’s Office 03-July-2014 16:31 IST. Available from: http://pib.nic.in/newsite/PrintRelease.aspx?relid=106055. Accessed September 30, 2014.

  4. Indian Academy of Pediatrics, Advisory Committee on Vaccines and Immunization Practices (ACVIP), Vashishtha VM, Yewale VN, Bansal CP, Mehta PJ. IAP perspectives on measles and rubella elimination strategies. Indian Pediatr. 2014;51:719–22.

    Article  Google Scholar 

  5. Centers for Disease Control and Prevention (CDC). Progress in implementing measles mortality reduction strategies—India, 2010–2011. Morb Mortal Wkly Rep. 2011;60:1315–9.

    Google Scholar 

  6. Simons E, Ferrari M, Fricks J, Wannemuehler K, Anand A, Burton A, et al. Assessment of the 2010 global measles mortality reduction goal: Results from a model of surveillance data. Lancet. 2012;379:2173–8.

    Article  PubMed  Google Scholar 

  7. Murhekar MV, Ahmad M, Shukla H, Abhishek K, Perry RT, Bose AS, et al. Measles case fatality rate in Bihar, India, 2011–12. PLoS One. 2014;9:e96668.

    Article  Google Scholar 

  8. Sudfeld CR, Halsey NA. Measles case fatality ratio in India a review of community based studies. Indian Pediatr. 2009;46:983–9.

    CAS  PubMed  Google Scholar 

  9. Morris SK, Awasthi S, Kumar R, Shet A, Khera A, Nakhaee F, et al. MDS Collaborators. Measles mortality in high and low burden districts of India: Estimates from a nationally representative study of over 12,000 child deaths. Vaccine. 2013;31:4655–61.

    Article  PubMed  Google Scholar 

  10. Garg S, Laskar AR. Measles elimination goal: Is it feasible for India? Indian J Public Health. 2010;54:190–3.

    Article  PubMed  Google Scholar 

  11. Gupta SK, Sosler S, Haldar P, Hombergh Hv, Bose AS. Introduction strategy of a second dose measles containing vaccine in India. Indian Pediatr. 2011;48:379–82.

    Article  PubMed  Google Scholar 

  12. Bhuniya S, Maji D, Mandal D, Mondal N. Measles outbreak among the Dukpa tribe of Buxa hills in West Bengal, India: Epidemiology and vaccine efficacy. Indian J Public Health. 2013;57:272–5.

    PubMed  Google Scholar 

  13. Mishra PP, Chauhan NT. Double outbreak of measles in the Talaja block of Bhavnagar district, Gujarat, India 2011: A need for improving the vaccine coverage and the community participation. J Clin Diagn Res. 2012;6:1713–7.

    PubMed Central  PubMed  Google Scholar 

  14. Murhekar MV, Hutin YJ, Ramakrishnan R, Ramachandran V, Biswas AK, Das PK, et al. The heterogeneity of measles epidemiology in India: implications for improving control measures. J Infect Dis. 2011;204:S421–6.

    Article  PubMed  Google Scholar 

  15. Wairagkar N, Chowdhury D, Vaidya S, Sikchi S, Shaikh N, Hungund L, et al. MeaslesNetIndia collaborators. Molecular epidemiology of measles in India, 2005–2010. J Infect Dis. 2011;204:S403–13.

    Article  PubMed  Google Scholar 

  16. Vaidya SR, Wairagkar NS, Raja D, Khedekar DD, Gunasekaran P, Shankar S, et al. First detection of measles genotype D7 from India. Virus Genes. 2008;36:31–4.

    Article  CAS  PubMed  Google Scholar 

  17. Shakya AK, Shukla V, Maan HS, Dhole TN. Identification of different lineages of measles virus strains circulating in Uttar Pradesh, North India. Virol J. 2012;9:237.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  18. Shakya AK, Shukla V, Maan HS, Dhole TN. Epidemiology and genetic relatedness of measles virus infection in Uttar Pradesh, India, during 2009–2010. Arch Virol. 2012,157:723–31.

    Article  CAS  Google Scholar 

  19. Ramamurty N, Raja D, Gunasekaran P, Varalakshmi E, Mohana S, Jin L. Investigation of measles and rubella outbreaks in Tamil Nadu, India-2003. J Med Virol. 2006;78:508–13.

    Article  PubMed  Google Scholar 

  20. Kuttiatt VS, Kalpathodi S, Gangadharan ST, Kailas L, Sreekumar E, Sukumaran SM, et al. Detection of measles virus genotype B3, India. Emerg Infect Dis. 2014;20:1764–6.

    Article  PubMed Central  PubMed  Google Scholar 

  21. Bhargava I, Chhaparwal BC, Phadke MA, Irani SF, Chhaparwal D, Dhorje S, et al. Immunogenicity and reactogenicity of indigenously produced MMR vaccine. Indian Pediatr. 1995;32:983–8.

    CAS  PubMed  Google Scholar 

  22. Raut SK, Kulkarni PS, Phadke MA, Jadhav SS, Kapre SV, Dhere RM, et al. Persistence of antibodies induced by measles-mumps-rubella vaccine in children in India. Clin Vaccine Immunol. 2007;14:1370–1.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  23. Gomber S, Arora SK, Das S, Ramachandran VG. Immune response to second dose of MMR vaccine in Indian children. Indian J Med Res. 2011;134:302–6.

    PubMed Central  CAS  PubMed  Google Scholar 

  24. Arunkumar G, Vandana KE, Sathiakumar N. Prevalence of measles, mumps, rubella, and varicella susceptibility among health science students in a University in India. Am J Ind Med. 2013;56:58–64.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  25. Vaidya SR, Brown DW, Jin L, Samuel D, Andrews N, Brown KE. Development of a focus reduction neutralization test (FRNT) for detection of mumps virus neutralizing antibodies. J Virol Methods. 2010;163:153–6.

    Article  CAS  PubMed  Google Scholar 

  26. Vaidya SR, Kumbhar NS, Bhide VS. Detection of measles, mumps and rubella viruses by immuno-colorimetric assay and its application in a focus reduction neutralization tests. Microbiol Immunol. 2014;58:666–74.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Measles Group, WHO Accredited National Reference Laboratory for Measles and Rubella, National Institute of Virology (Indian Council of Medical Research), 20-A, Dr Ambedkar Road, Post Box 11, 411 001, Pune, India

    Sunil R. Vaidya

Authors
  1. Sunil R. Vaidya
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Sunil R. Vaidya.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Vaidya, S.R. Commitment of measles elimination by 2020: Challenges in India. Indian Pediatr 52, 103–106 (2015). https://doi.org/10.1007/s13312-015-0580-7

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13312-015-0580-7

Keywords

Search

Navigation